Redhawk Wealth Advisors’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-21,361
Closed -$1.84M 322
2024
Q4
$1.84M Buy
21,361
+2,406
+13% +$260K 0.25% 82
2024
Q3
$2.26M Sell
18,955
-372
-2% -$49.6K 0.32% 75
2024
Q2
$2.76M Buy
19,327
+2,314
+14% +$307K 0.42% 56
2024
Q1
$2.18M Buy
17,013
+4,206
+33% +$501K 0.36% 61
2023
Q4
$1.32M Buy
12,807
+651
+5% +$64.4K 0.26% 87
2023
Q3
$1.11M Buy
12,156
+1,376
+13% +$121K 0.37% 65
2023
Q2
$872K Buy
10,780
+3,748
+53% +$306K 0.27% 82
2023
Q1
$560K Buy
7,032
+1,182
+20% +$83.8K 0.19% 103
2022
Q4
$396K Buy
+5,850
New +$343K 0.15% 130

Other funds holding NVO

Redhawk Wealth Advisors's NVO Position: Q1 2025 in Review

Redhawk Wealth Advisors sold out of Novo Nordisk (NVO) in Q1 2025, closing a stake of 21,361 shares — an estimated $1.84M sold.

Redhawk Wealth Advisors first reported a position in NVO in Q4 2022 and held it in 9 quarters. The position peaked at $2.76M in Q2 2024. 1,528 funds tracked by Wall St. Rank hold NVO as of Q1 2025.

  • Redhawk Wealth Advisors reported no remaining Novo Nordisk position as of Q1 2025 after selling out during the quarter.
  • Redhawk Wealth Advisors sold 21,361 Novo Nordisk shares in Q1 2025, an estimated $1.84M.
  • Redhawk Wealth Advisors first reported a position in Novo Nordisk in Q4 2022 and held it in 9 quarters.
  • Redhawk Wealth Advisors's Novo Nordisk position peaked at $2.76M in Q2 2024.
  • 1,528 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2025.

Based on Redhawk Wealth Advisors's 13F filing for Q1 2025, filed 15 Apr 2025.